ASLAN Pharmaceuticals Share Price - ASLN

1.84
0.04 (2.22%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
ASLAN Pharmaceuticals Ltd ASLN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.14 -7.22% 1.80 1.67 1.8778 1.81 1.94 20:00:00
Bid Price Ask Price Spread Spread % News
1.72 2.00 0.28 14.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
483 208,754  1.80  375,456 391,919 0.35 - 8.18
Last Trade Time Type Quantity Stock Price Currency
16:20:09 formt 100  1.84 USD

ASLAN Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
 68.38M 37.99M  -1.27B -1.39 - 37.99M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News ASLAN Pharmaceuticals

Loading Messages....

Latest ASLN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

ASLN Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

ASLAN Pharmaceuticals Ltd is a clinical-stage oncology-focused biotechnology company. It is developing novel therapeutics for global markets. The company's portfolio consists of four product candidates which target validated growth pathways applied to new patient segments and novel cancer metabolic pathways. The company targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.


Your Recent History
NASDAQ
ASLN
ASLAN Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.